Clinical trial
Evaluation of the Safety and Effectiveness of EPI-linked Malaria Intermittent Chemotherapy and Iron Supplementation
NCT00857077 is registered in ClinicalTrials.gov with London School of Hygiene and Tropical Medicine as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Evaluation of the Safety and Effectiveness of EPI-linked Malaria Intermittent Chemotherapy and Iron Supplementation
- Lead sponsor
- London School of Hygiene and Tropical Medicine
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- September 30, 2000
- Completion date
- June 30, 2004
- Enrollment
- 2,485 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
anaemia, malaria